RYM Stock Chart & Stats
$2.17
-$0.05(-2.25%)
―
--
Day’s Range― - ―
52-Week Range$1.99 - $3.05
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.12M
Market Cap
$2.20B
Enterprise Value$3.94B
Total Cash (Recent Filing)$9.70M
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Dec 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding1,015,729,060
10 Day Avg. Volume926,656
30 Day Avg. Volume1,120,661
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)0.53
Price to Sales (P/S)2.70
P/FCF Ratio7.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.05
Revenue Forecast (FY)$948.63M
Ryman Healthcare News
RYM FAQ
What was Ryman Healthcare Ltd.’s price range in the past 12 months?
Ryman Healthcare Ltd. lowest stock price was $1.99 and its highest was $3.05 in the past 12 months.
What is Ryman Healthcare Ltd.’s market cap?
Ryman Healthcare Ltd.’s market cap is $2.20B.
When is Ryman Healthcare Ltd.’s upcoming earnings report date?
Ryman Healthcare Ltd.’s upcoming earnings report date is Dec 02, 2026 which is in 152 days.
How were Ryman Healthcare Ltd.’s earnings last quarter?
Ryman Healthcare Ltd. released its earnings results on May 25, 2026. The company reported -$0.124 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.124.
Is Ryman Healthcare Ltd. overvalued?
According to Wall Street analysts Ryman Healthcare Ltd.’s price is currently Undervalued.
Does Ryman Healthcare Ltd. pay dividends?
Ryman Healthcare Ltd. does not currently pay dividends.
What is Ryman Healthcare Ltd.’s EPS estimate?
Ryman Healthcare Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ryman Healthcare Ltd. have?
Ryman Healthcare Ltd. has 1,015,729,060 shares outstanding.
What happened to Ryman Healthcare Ltd.’s price movement after its last earnings report?
Ryman Healthcare Ltd. reported an EPS of -$0.124 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.37%.
Which hedge fund is a major shareholder of Ryman Healthcare Ltd.?
Currently, no hedge funds are holding shares in NZ:RYM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ryman Healthcare Ltd.
Ryman Healthcare Limited, established in Christchurch, New Zealand, in 1984, specializes in the development, ownership, and management of all-encompassing retirement communities for seniors. Operating across both New Zealand and Australia, the company provides a wide array of living and care solutions. These range from independent townhouses and apartments to serviced accommodations, complemented by dedicated care facilities offering residential, hospital, and specialized dementia care, alongside respite and day care services. Each of these integrated villages is equipped with extensive amenities, including indoor heated swimming pools, fitness centers, libraries, dining rooms, internet cafes, bars, retail outlets, movie theaters, bowling greens, and beauty and hairdressing salons. As of May 20, 2022, Ryman Healthcare oversaw 45 retirement villages, encompassing roughly 8,538 independent living units and 4,239 care beds.
RYM Company Deck
RYM Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reported clear operational progress: doubled operating EBITDAF, strong aged-care performance (EBITDAF per bed +31%), significant cost savings ($57m), positive free cash flow of $188m, reduced development exposure and a strengthened balance sheet (refinancing, lower interest costs). Management acknowledges remaining challenges — resale stock and margins, timing of DMF cash benefits, one-off transformation costs, FX effects and regional market competitiveness — and provided targets and actions (sales/marketing investment, land divestments, product changes, and a $150m CFEO improvement target to FY'29). Overall the positives — particularly cash generation, cost-out, and aged care momentum — materially outweigh the current lowlights, supporting a constructive outlook while risks from market conditions and timing remain.View all NZ:RYM earnings summariesRYM Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
―Technical Analysis
1 Day
3 Days
1 Week
1 Month
Oceania Healthcare
―
Summerset Group Holdings Limited
―
Promisia Healthcare Limited
―
Third Age Health Services Limited
―
Radius Residential Care Ltd
―
Options Prices
Currently, No data available
---








